Literature DB >> 20185288

Opioid substitution therapy in Tajikistan: Another perpetual pilot?

Alisher Latypov1.   

Abstract

BACKGROUND: Opioid substitution therapy (OST) continues to face strong resistance in the former Soviet Central Asian republics. OST was discontinued by the Uzbek government in 2009. In Kyrgyzstan, with about 950 people currently receiving OST, the programme was about to be suspended in 2009. In Kazakhstan, a small pilot project serves 50 clients. Turkmenistan may introduce OST in 2010, while the Tajik Ministry of Health approved the introduction of an OST pilot in summer 2009.
METHODS: This paper draws upon the analysis of interests of the OST-affected groups in Tajikistan as a case study to understand the roots of resistance to OST.
RESULTS: In Tajikistan, OST may be contrary to the interests of some narcologists, law enforcement officers and drug dealers. People who use drugs do not play any role in national drug-policy making. The HIV prevention community within the Tajik executive bodies receives major financial support from the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) to respond to an IDU driven epidemic, and yet it is the only group which has nothing to gain from the absence of OST.
CONCLUSION: The Tajik government agreed to introduce OST in order not to jeopardize its future funding from GFATM. If the interests of the OST-affected groups are ignored, there is a high chance that OST in Tajikistan may remain a perpetual pilot project even despite all the necessary resources would come from GFATM and other donors. Putting "narcology on pilot" may prove helpful in both tackling the OST "perpetual pilots" and shifting the focus of public attention towards major inadequacies of the existing state-funded drug treatment systems in the region. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20185288     DOI: 10.1016/j.drugpo.2010.01.013

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  3 in total

Review 1.  HIV, Drug Injection, and Harm Reduction Trends in Eastern Europe and Central Asia: Implications for International and Domestic Policy.

Authors:  Katherine LaMonaca; Kostyantyn Dumchev; Sergii Dvoriak; Lyuba Azbel; Olga Morozova; Frederick L Altice
Journal:  Curr Psychiatry Rep       Date:  2019-06-03       Impact factor: 5.285

2.  The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential.

Authors:  Tim Rhodes
Journal:  Soc Sci Med       Date:  2018-02-10       Impact factor: 4.634

Review 3.  The long winding road of opioid substitution therapy implementation in South-East Asia: challenges to scale up.

Authors:  Gary Reid; Mukta Sharma; Peter Higgs
Journal:  J Public Health Res       Date:  2014-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.